EODData

NASDAQ, DRMA:

03 Oct 25 15:41
LAST:

4.860

CHANGE:
 0.05
OPEN:
4.760
HIGH:
5.020
ASK:
0.000
VOLUME:
23.7K
CHG(%):
1.02
PREV:
4.910
LOW:
4.760
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Oct 254.9805.0204.8124.86028.3K
02 Oct 255.0105.2204.5504.910522.3K
01 Oct 255.0205.1704.9805.13011.9K
30 Sep 255.2005.2004.9605.02013.1K
29 Sep 255.1905.3805.1005.20027.1K
26 Sep 254.6505.2704.6505.19082K
25 Sep 254.9305.0204.5904.65020.6K
24 Sep 255.2105.2304.8604.92729.8K
23 Sep 255.4505.5205.1905.20023.5K
22 Sep 255.6705.6705.3005.38010.9K

COMPANY PROFILE

Name:Dermata Therapeutics Inc
About:Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its lead product candidate is XYNGARI, which is in Phase 3 clinical studies for the treatment of moderate-to-severe acne, as well as completed Phase 1b proof of concept (POC) trial for mild-to-moderate psoriasis. The company is also developing DMT410 that has completed Phase 1b POC trials for the treatment of axillary hyperhidrosis and aesthetic skin conditions. It has a clinical trial collaboration agreement with Revance Therapeutics, Inc. to conduct a multi-center clinical trial to evaluate the topical application of XYNGARI with DAXXIFY, Revance's botulinum toxin type A. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
Website:https://www.dermatarx.com
CUSIP:249845108
CIK:0001853816
ISIN:US2498451085
FIGI:BBG011DJT0X2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:0.23
Price to Book:0.60
Shares:681.6K
Market Cap:3.31M

TECHNICAL INDICATORS

MA5:5.02
MA10:5.05
MA20:5.26
MA50:5.14
MA100:2.92
MA200:2.01
STO9:24.14
STO14:13.34
RSI14:40.92
WPR14:-83.27
MTM14:-1.05
ROC14:-0.18
ATR:0.42
Week High:5.38
Week Low:4.55
Month High:6.22
Month Low:4.55
Year High:7.14
Year Low:0.57
Volatility:43.97

RECENT SPLITS

Date Ratio
01 Aug 20251-10
16 May 20241-15
14 Mar 20231-16